Loading clinical trials...
Loading clinical trials...
The hypothesis of this study was that gastric bypass (GBP) ameliorates gastroesophageal reflux disease (GERD) in morbidly obese patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Clinica Gastrobese
NCT07565051 · Morbid Obesity Requiring Bariatric Surgery
NCT06132477 · Morbid Obesity, Metabolic Syndrome, and more
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT05569681 · Morbid Obesity
NCT07289555 · Morbid Obesity, Bariatric Surgery, and more
Clínica Gastrobese
Passo Fundo, Rio Grande do Sul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions